Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial
•Infants of mothers who participated in a phase IV maternal pertussis immunization trial (NCT02377349) received hexavalent DTaP and PCV13 primary series.•High levels of maternally transferred pertussis antibodies persisted in infants from Tdap-vaccinated mothers until 2–3 months after birth.•These m...
Gespeichert in:
Veröffentlicht in: | Vaccine 2020-02, Vol.38 (8), p.2105-2114 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!